Literature DB >> 10529248

Determinants for differential effects on D-Ala-D-lactate vs D-Ala-D-Ala formation by the VanA ligase from vancomycin-resistant enterococci.

I A Lessard1, V L Healy, I S Park, C T Walsh.   

Abstract

Bacteria with either intrinsic or inducible resistance to vancomycin make peptidoglycan (PG) precursors of lowered affinity for the antibiotic by switching the PG-D-Ala-D-Ala termini that are the antibiotic-binding target to either PG-D-Ala-D-lactate or PG-D-Ala-D-Ser as a consequence of altered specificity of the D-Ala-D-X ligases in the cell wall biosynthetic pathway. The VanA ligase of vancomycin-resistant enterococci, a D-Ala-D-lactate depsipeptide ligase, has the ability to recognize and activate the weak nucleophile D-lactate selectively over D-Ala(2) to capture the D-Ala(1)-OPO(3)(2)(-) intermediate in the ligase active site. To ensure this selectivity in catalysis, VanA largely rejects the protonated (NH(3)(+)) form of D-Ala at subsite 2 (K(M2) of 210 mM at pH 7.5) but not at subsite 1. In contrast, the deprotonated (NH(2)) form of D-Ala (K(M2) of 0.66 mM, k(cat) of 550 min(-)(1)) is a 17-fold better substrate compared to D-lactate (K(M) of 0.69 mM, k(cat) of 32 min(-)(1)). The low concentration of the free amine form of D-Ala at physiological conditions (i.e., 0.1% at pH 7.0) explains the inefficiency of VanA in dipeptide synthesis. Mutational analysis revealed a residue in the putative omega-loop region, Arg242, which is partially responsible for electrostatically repelling the protonated form of D-Ala(2). The VanA enzyme represents a subfamily of D-Ala-D-X ligases in which two key active-site residues (Lys215 and Tyr216) in the active-site omega-loop of the Escherichia coli D-Ala-D-Ala ligase are absent. To look for functional complements in VanA, we have mutated 20 residues and evaluated effects on catalytic efficiency for both D-Ala-D-Ala dipeptide and D-Ala-D-lactate depsipeptide ligation. Mutation of Asp232 caused substantial defects in both dipeptide and depsipeptide ligase activity, suggesting a role in maintaining the loop position. In contrast, the H244A mutation caused an increase in K(M2) for D-lactate but not D-Ala, indicating a differential role for His244 in the recognition of the weaker nucleophile D-lactate. Replacement of the VanA omega-loop by that of VanC2, a D-Ala-D-Ser ligase, eliminated D-Ala-D-lactate activity while improving by 3-fold the catalytic efficacy of D-Ala-D-Ala and D-Ala-D-Ser activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529248     DOI: 10.1021/bi991384c

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  The molecular basis of vancomycin resistance in clinically relevant Enterococci: crystal structure of D-alanyl-D-lactate ligase (VanA).

Authors:  D I Roper; T Huyton; A Vagin; G Dodson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

2.  Structural and enzymatic characterization of BacD, an L-amino acid dipeptide ligase from Bacillus subtilis.

Authors:  Yasuhito Shomura; Emi Hinokuchi; Hajime Ikeda; Akihiro Senoo; Yuichi Takahashi; Jun-ichi Saito; Hirofumi Komori; Naoki Shibata; Yoshiyuki Yonetani; Yoshiki Higuchi
Journal:  Protein Sci       Date:  2012-03-30       Impact factor: 6.725

3.  D-Ala:D-Ala ligase gene flanking the vanC cluster: evidence for presence of three ligase genes in vancomycin-resistant Enterococcus gallinarum BM4174.

Authors:  Ole-Herman Ambúr; Peter E Reynolds; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Substrate Inhibition of VanA by d-Alanine Reduces Vancomycin Resistance in a VanX-Dependent Manner.

Authors:  Lizah T van der Aart; Nicole Lemmens; Willem J van Wamel; Gilles P van Wezel
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

5.  Structural and functional characterization of VanG D-Ala:D-Ser ligase associated with vancomycin resistance in Enterococcus faecalis.

Authors:  Djalal Meziane-Cherif; Frederick A Saul; Ahmed Haouz; Patrice Courvalin
Journal:  J Biol Chem       Date:  2012-09-11       Impact factor: 5.157

6.  Putative VanRS-like two-component regulatory system associated with the inducible glycopeptide resistance cluster of Paenibacillus popilliae.

Authors:  Henry Fraimow; Christopher Knob; Inmaculada A Herrero; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

7.  Crystallization and preliminary X-ray analysis of a D-Ala:D-Ser ligase associated with VanG-type vancomycin resistance.

Authors:  Patrick Weber; Djalal Meziane-Cherif; Ahmed Haouz; Frederick A Saul; Patrice Courvalin
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-09-23

Review 8.  Molecular mechanisms of vancomycin resistance.

Authors:  Peter J Stogios; Alexei Savchenko
Journal:  Protein Sci       Date:  2020-01-23       Impact factor: 6.725

9.  VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on vancomycin for growth.

Authors:  Carole Moubareck; Djalal Meziane-Cherif; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

10.  Crystallization and preliminary X-ray analysis of a D-alanyl-D-alanine ligase (EcDdlB) from Escherichia coli.

Authors:  Sarah Batson; Dean Rea; Vilmos Fülöp; David I Roper
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.